Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05984589 · ClinicalTrials.gov registry record · NA

Personalized Health Self-Management Training for Colorectal Cancer Survivors

A NA study of Colorectal Cancer and Health Behavior, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT05984589: Recruiting NA study of Colorectal Cancer and Health Behavior, sponsored by University of Southern California.

NCT05984589 is a NA study of Colorectal Cancer and Health Behavior that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 120 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05984589, a NA study of Colorectal Cancer and Health Behavior, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

This is a Phase 2 prospective, randomized, controlled, double-arm study to assess personalized self-management training (PSMT) intervention efficacy and patient experiences compared to standardized self-management training (SSMT). A total of 120 colorectal cancer (CRC) patients will be enrolled and randomized 1:1 to complete a 6-week self-management training program (either PSMT or SSMT) to be carried out by licensed occupational therapists with doctoral training. This study aims to examine whether PSMT is more effective in increasing adherence to healthy behavior recommendations compared to SSMT in CRC patients.

Primary Outcome

Outcome measures contributing to each component of WCRF/AICR Healthy Behavior Adherence scale will be collected from baseline and end-of-study visits (Session 6 and Follow-up). The WCRF/AICR scale comprises of 7 categories with each category given a score for non-/low adherence, moderate/some adherence, or full adherence to each HBR. Total value ranges from 0 to 7 points, with a higher score indicating better adherence. HBR items include body composition, physical activity, diet, and alcohol use

Interventions

  • BEHAVIORAL RISE Personalized Self-Management Training (PSMT)
  • BEHAVIORAL Standardized Self-Management Training (SSMT)

Study Locations (2)

California

  • Cedars-Sinai Medical Center - Los Angeles
  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-03-01
Est. Completion 2028-11-30
Phase NA
University of Southern California

617 total trials

What NCT05984589 shows while recruiting

NCT05984589 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (92% lower).

The record links to 4 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which RISE Personalized Self-Management Training (PSMT) is the first listed.

NCT05984589 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05984589 about?

NCT05984589 is a clinical study titled "Personalized Health Self-Management Training for Colorectal Cancer Survivors". This is a Phase 2 prospective, randomized, controlled, double-arm study to assess personalized self-management training (PSMT) intervention efficacy and patient experiences compared to standardized self-management training (SSMT). A total of 120 colorectal cancer (CRC) patients will be enrolled and ...

What is the current status of trial NCT05984589?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-03-01. Estimated completion is 2028-11-30.

What conditions does trial NCT05984589 study?

This clinical trial studies the following conditions: Colorectal Cancer, Health Behavior, Behavior, Health, Healthy Lifestyle.

What interventions are being tested in trial NCT05984589?

The interventions under investigation include: RISE Personalized Self-Management Training (PSMT) (BEHAVIORAL), Standardized Self-Management Training (SSMT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05984589?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05984589 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05984589's enrollment target sits among peer trials

120 199th of 381 higher than 178 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05984589, the US trial registry maintained by the National Library of Medicine. NCT05984589 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.